Market Place
Sourcing Support
Mithra sells Estetra SRL, Neuralis SA and specific assets to Gedeon Richter
11 Jun 2024 //
PRESS RELEASE
Mithra files for bankruptcy and continues negotiations with Gedeon Richte
10 Jun 2024 //
PRESS RELEASE
Mithra applies for extension of court protection measures to advance process
04 Jun 2024 //
PRESS RELEASE
Mithra receives additional EUR 2.5 million to advance monetization
29 May 2024 //
PRESS RELEASE
Mithra announces grant of two additional U.S. patents for NEXTSTELLIS®
10 May 2024 //
PRESS RELEASE
Mithra enters into exclusive negotiations with Gedeon Richter
03 May 2024 //
PRESS RELEASE
Mithra updates on offers received in the context of its monetization process
29 Apr 2024 //
PRESS RELEASE
Early data from Mithra’s ESTELLE® pediatric study at two upcoming congresses
16 Apr 2024 //
PRESS RELEASE
Mithra updates on its ongoing monetization process
28 Mar 2024 //
PRESS RELEASE
Mithra announces updates to its 2024 financial calendar
28 Mar 2024 //
PRESS RELEASE
Mithra reaches milestone in estetrol skin study
08 Mar 2024 //
PRESS RELEASE
Mithra gears up to enter the immune-oncology race
15 Jun 2023 //
CLINICAL TRIALS ARENA
Publication of a transparency notification received from Scorpiaux BV
06 Jun 2023 //
PRESS RELEASE
Mithra Appoints Executive Christian Homsy as Chairman
29 May 2023 //
PRESS RELEASE
Mithra’s Meeting Approves the Renewal of its Board of Directors
25 May 2023 //
PRESS RELEASE
Payment of the interests of the Highbridge/Whitebox loans
12 May 2023 //
PRESS RELEASE
Mithra announces completion of recruitment in study of Estelle in patients
11 May 2023 //
PRESS RELEASE
Mithra and the University of Liège Secure Proof-of-Concept for E4
04 May 2023 //
PRESS RELEASE
Publication of a transparency notification received from Alychlo NV
28 Apr 2023 //
PRESS RELEASE
Mithra Releases Invitation to its General Shareholders’ Meeting
25 Apr 2023 //
PRESS RELEASE
Mithra releases 2022 Annual Report
18 Apr 2023 //
PRESS RELEASE
FDA approval, partnership on agenda at Mithra as phase 3 hits
15 Jan 2022 //
FIERCEBIOTECH
Mithra Provides FDA Update on Myring
06 Oct 2021 //
MARKETSCREENER
Mithra and Searchlight Pharma Announce Availability of Nextstellis
15 Sep 2021 //
NEWSWIRE
ExeVir and Mithra announce manufacturing collaboration
15 Jul 2021 //
PR NEWSWIRE
Mithra Signs License & Supply Agreement Commercialization of Myring in Mexico
14 Jul 2020 //
PRESS RELEASE
Mayne, Mithra bring novel oral contraception in the US
02 Oct 2019 //
PRNASIA
